These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34411156)

  • 1. HIV and antiretroviral treatment knowledge gaps and psychosocial burden among persons living with HIV in Lima, Peru.
    Navarro R; Paredes JL; Echevarria J; González-Lagos E; Graña A; Mejía F; Otero L
    PLoS One; 2021; 16(8):e0256289. PubMed ID: 34411156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Depression Among Middle-Aged to Older People Living With HIV in Lima, Peru.
    Failoc-Rojas VE; Jia DT; Gil-Zacarias M; Latorre A; Cabello R; Garcia PJ; Diaz MM
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241273452. PubMed ID: 39140382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis Knowledge among Persons Living with HIV Attending a Tertiary Hospital in Lima, Peru.
    Paredes JL; Navarro R; Echevarria J; Seas C; Prochazka M; Otero L
    Am J Trop Med Hyg; 2023 Dec; 109(6):1266-1269. PubMed ID: 37783463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
    Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
    Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with HIV Viral Suppression Among Transgender Women in Lima, Peru.
    Rich KM; Wickersham JA; Valencia Huamaní J; Kiani SN; Cabello R; Elish P; Florez Arce J; Pizzicato LN; Soria J; Sanchez J; Altice FL
    LGBT Health; 2018; 5(8):477-483. PubMed ID: 30874476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical situation of Venezuelan migrants living with HIV in a hospital in Lima, Peru.
    Huerta-Vera GS; Amarista MA; Mejía FA; Graña AB; Gonzalez-Lagos EV; Gotuzzo E
    Int J STD AIDS; 2021 Oct; 32(12):1157-1164. PubMed ID: 34156882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding health-related behavior among adolescents living with HIV in Lima, Peru.
    Rodriguez CA; Valle E; Galea J; Wong M; Kolevic L; Muñoz M; Lecca L; Franke MF
    BMC Pediatr; 2019 Oct; 19(1):396. PubMed ID: 31666037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective evaluation of highly active antiretroviral therapy simplification in patients with end-stage renal disease receiving hemodialysis.
    Otto A; Pecora Fulco P
    Int J STD AIDS; 2021 Sep; 32(10):963-967. PubMed ID: 33969749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV screening among newly diagnosed TB patients: a cross sectional study in Lima, Peru.
    Ramírez S; Mejía F; Rojas M; Seas C; Van der Stuyft P; Gotuzzo E; Otero L
    BMC Infect Dis; 2018 Mar; 18(1):136. PubMed ID: 29558891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population-based survey, 2018.
    Abimiku A; Ramadhani HO; Moloney M; Stafford KA; Chang JC; Patel HK; Domaoal RA; Okoye M; Jelpe T; Bronson M; Ibrahim D; Swaminathan M; Gambo A; Charurat ME;
    HIV Med; 2023 Jul; 24(7):827-837. PubMed ID: 36945183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care-Specific Enacted HIV-Related Stigma's Association with Antiretroviral Therapy Adherence and Viral Suppression Among People Living with HIV in Florida.
    Algarin AB; Sheehan DM; Varas-Diaz N; Fennie KP; Zhou Z; Spencer EC; Cook RL; Morano JP; Ibanez GE
    AIDS Patient Care STDS; 2020 Jul; 34(7):316-326. PubMed ID: 32639208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
    Althoff KN; Buchacz K; Hall HI; Zhang J; Hanna DB; Rebeiro P; Gange SJ; Moore RD; Kitahata MM; Gebo KA; Martin J; Justice AC; Horberg MA; Hogg RS; Sterling TR; Cescon A; Klein MB; Thorne JE; Crane HM; Mugavero MJ; Napravnik S; Kirk GD; Jacobson LP; Brooks JT;
    Ann Intern Med; 2012 Sep; 157(5):325-35. PubMed ID: 22944874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention and Viral Suppression Among Adolescents Newly Initiating Antiretroviral Therapy in Adult HIV Care in Lima, Peru: A Retrospective Cohort Study.
    Niwa M; Matos E; Rodriguez C; Wong M; Errea RA; Ramos A; Senador L; Contreras C; Galea JT; Lindeborg A; Benites C; Shin SS; Lecca L; Franke MF
    J Adolesc Health; 2024 Feb; 74(2):260-267. PubMed ID: 37804297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
    Young PW; Zielinski-Gutierrez E; Wamicwe J; Mukui I; Kim AA; Waruru A; Zeh C; Kretzschmar ME; De Cock KM
    AIDS; 2020 Mar; 34(4):631-636. PubMed ID: 31794520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States.
    Nyaku M; Beer L; Shu F
    AIDS Care; 2019 May; 31(5):599-608. PubMed ID: 30309269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.
    Mukui IN; Ng'ang'a L; Williamson J; Wamicwe JN; Vakil S; Katana A; Kim AA
    PLoS One; 2016; 11(12):e0167465. PubMed ID: 27907114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
    Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
    Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana use and viral suppression in persons receiving medical care for HIV-infection.
    Okafor CN; Zhou Z; Burrell LE; Kelso NE; Whitehead NE; Harman JS; Cook CL; Cook RL
    Am J Drug Alcohol Abuse; 2017 Jan; 43(1):103-110. PubMed ID: 27398989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.